The Research & Development Council of New Jersey (R&D Council) announced the results of its 2023 election. Two members of the Council’s Executive Committee were newly elected to positions and one incumbent member was reelected:
Avantor Performance Materials, Casabona Ventures, Lexicon Pharmaceuticals, Merck & Co., Montclair State University and Stockton University were all elected as organizations to serve on the Council’s Board of Directors for three-year terms, from 2023-2026.
Dr. Ruegger has been a dedicated member of the Council’s Board of Directors, serving as the Novartis representative, and most recently serving as the Board’s Secretary. Dr. Davies is newly elected to the role of Secretary. Ms. Maillard will begin her second term as the Board’s Vice-Chair and Mr. Stokes will continue in his role as Treasurer. Anthony S. Cicatiello will continue to serve in his appointed role as Council President. All will serve on the Board’s Executive Committee.
“The Council’s mission to serve as a unified voice for R&D, STEM and innovation in New Jersey is reflected in the election results,” said new R&D Council Chair Colleen Ruegger. “We have incredible depth of STEM expertise and leadership represented in our new Executive Committee and I have no doubt that this leadership will sustain and advance the Council’s work as it has for the past 60 years here in New Jersey, and beyond.”
To access more business news, visit NJB News Now.Related Articles: